NRG HN004
Randomized Phase II/III Trial of Radiotherapy With Concurrent Durvalumab vs. Radiotherapy With Concurrent Cetuximab in Patients With Stage III-IVB Head and Neck Cancer With a Contraindication to Cisplatin
More Information
NRG HN004
Randomized Phase II/III Trial of Radiotherapy With Concurrent Durvalumab vs. Radiotherapy With Concurrent Cetuximab in Patients With Stage III-IVB Head and Neck Cancer With a Contraindication to Cisplatin
More Information
